Biogen partnered with T Brand to share the story of Matt Lafleur, who was diagnosed at an early age with Friedreich ataxia, or F.A., a rare and progressive neurodegenerative disease. The piece details his journey of recovery and efforts in the F.A. community, along with Biogen’s SKYCLARYS, their newest treatment for this disease.

︎︎︎View the Full Page ︎︎︎ here